FDA Inspection 935613 - Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center - June 26, 2015
FDA Inspection 935613 for Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center on June 26, 2015. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 935613 for Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center on June 26, 2015. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
June 26, 2015
Product Type
Biologics
ID: a97aafbd-6d06-43b0-b30f-5df66e755feb
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox